Related Experiment Video
Updated: Aug 23, 2025

09:47
Analysis of Histone Antibody Specificity with Peptide Microarrays
Published on: August 1, 2017
40.6K
EPIphany-A Platform for Analysis and Visualization of Peptide Immunoarray Data
Zoe Parker Cates1, Antonio Facciuolo2, Daniel Hogan1
1Department of Computer Science, University of Saskatchewan, Saskatoon, SK, Canada.
Frontiers in Bioinformatics
|October 28, 2022
Summary
EPIphany software offers a user-friendly platform for analyzing antibody responses using immunoarrays. This tool simplifies the examination of antibody reactivity and diversity, aiding vaccine development.
Area of Science:
- Immunology
- Bioinformatics
Background:
- Antibodies are key to the humoral immune system, crucial for pathogen defense and vaccine responses.
- Understanding antibody reactivity to antigenic determinants is vital for vaccine development.
- Advanced techniques for antibody analysis are often inaccessible due to cost and expertise requirements.
Purpose of the Study:
- To introduce EPIphany, a novel software platform designed for analyzing antibody reactivity and diversity.
- To provide a user-friendly, web-based interface for researchers to interpret immunoarray data.
- To facilitate the discovery and development of novel immunotherapeutics through accessible data analysis.
Main Methods:
- Development of EPIphany, a web-based software platform with a graphical user interface.
- Implementation of data normalization options and various visualization tools for immunoarray data.
- Focus on biological users to ensure ease of use and accessibility.
Main Results:
- EPIphany provides essential analysis parameters and data normalization for immunoarray data.
- The platform offers unique visualization options for exploring antibody reactivity and diversity.
- It empowers researchers to extract biologically meaningful insights from complex datasets.
Conclusions:
- EPIphany addresses the need for user-friendly tools in immunoarray data analysis.
- The software enhances the ability to study antibody populations and antigenic determinants.
- EPIphany facilitates the development of new vaccines and immunotherapeutics.

